Refractory Solid Tumors

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children

Personalized KSX01-TCRT in Patients With Advanced Solid Tumors

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)

A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma

Nanoliposomal Irinotecan (Nal-IRI, ONIVYDE®) in Combination With TAS-102 (LONSURF®) in Refractory Solid Tumors

MyCustom:Prospective Master Protocol Trial on Precision Medicine Treatment for Refractory Solid Tumors

A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval

KSX01-TCRT Injection Project in Solid Tumors

KSH01-TCRT Solid Tumors

Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors

Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors

Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid Tumors

Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors

Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid Tumors

Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors

A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors